NSTK · 01.2026Independent supplement reference
NutriStack
Edition 1.0Reviewed May 26, 2026

Kava

Herb ·Moderate evidence ·Reviewed May 2026

Kava root preparations have randomized-trial and systematic-review evidence for anxiety symptom reduction, but safety concerns include rare severe liver injury and additive sedation. Risk appears influenced by dose, duration, plant part, cultivar, extraction method, product quality, alcohol, and comedications. Kava should be avoided in liver disease, pregnancy, heavy alcohol use, and with sedatives unless clinician-supervised.

What it's good for
  • May reduce anxiety symptom scores2,1
  • May promote relaxation
  • May reduce muscle tension
  • May support sleep when anxiety-related1,2
What to watch for
  • Drowsiness
  • Dizziness
  • GI upset
  • Liver disease or elevated liver enzymes2,3
  • Heavy alcohol use

The bottom line

Evidence rating moderate. Most-documented uses: may reduce anxiety symptom scores, may promote relaxation, may reduce muscle tension. 3 sources indexed (2003–2013), with 3 interaction records on file.

The science

How it works, mechanistically.

Core mechanism

Kavalactones such as kavain, dihydrokavain, methysticin, and yangonin modulate neuronal excitability through sodium and calcium channels, GABAergic tone, monoamine signaling, and limbic arousal pathways. These mechanisms can produce anxiolysis and muscle relaxation but also sedation and psychomotor impairment. Hepatotoxicity appears idiosyncratic or product-quality related in some cases, so conservative use and quality sourcing are essential.

Class
Kavalactone anxiolytic with hepatic safety concerns
Found in food
Traditional kava beverage prepared from root and rhizome
Low-status signs
None - kava is not an essential nutrient and has no deficiency state
Absorption
Fat-soluble; take with food
Dosing

Dosing & protocol.

Common range
60-250 mg/day total kavalactones for short-term use in clinical anxiety studies; avoid prolonged or high-dose use
Recommended form
Noble kava root-only aqueous or well-characterized extract with disclosed kavalactone dose

Taking with food may reduce GI upset. Avoid alcohol and avoid products made from aerial parts or unclear extracts.

Forms

Forms & what to buy.

Ranked by evidence and value.

Standardized Kavalactone Extract Recommended
Clinically interpretable when total kavalactones and plant part are disclosed. Take with food and no alcohol.
Mid60-120 mg/day kavalactones initially
Traditional Noble Kava Beverage
Preparation varies but root-only noble kava is preferred over unclear extracts. Avoid alcohol and sedatives.
MidProduct-specific kavalactone estimate
High-Potency Kava Capsule
Higher kavalactone exposure may increase adverse effect risk. Use only short term if at all.
PremiumAvoid exceeding label or clinician guidance
Cost

What it actually costs.

Real-world pricing across three quality tiers. Assumes Standardized kava root extract.

BudgetBest value
$6 /mo
$0.20 per dose
Mid
$17 /mo
$0.55 per dose
Premium
$45 /mo
$1.50 per dose

Quality-tested root-only products are preferred even if they cost more. Updated 2026-06-04.

Goals

Goal-based dosing.

Short-Term Anxiety Support

Dose: 60-250 mg/day total kavalactones1,2

Timing: Evening or divided doses

Use the lowest effective dose for the shortest duration and avoid alcohol.

Relaxation

Dose: Low-dose traditional beverage or 60-120 mg kavalactones

Timing: Evening

Avoid driving or machinery after use.

Sleep When Anxiety-Related

Dose: 60-120 mg kavalactones in evening1,2

Timing: 30-60 minutes before bed

Not first-line for chronic insomnia because hepatic and sedation risks limit use.

Lab work

Markers to track.

What to test, the optimal window inside the conventional range, and how long a response takes.

Alanine Aminotransferase ALT

Should remain stable; elevations may indicate liver stress or unrelated liver disease.

Optimal
7–35 U/L
Conventional
7–55 U/L
Responds in
Baseline and within 2-6 weeks if using longer than occasional short-term use

Stop kava and seek medical care for jaundice, dark urine, severe fatigue, right upper quadrant pain, or unexplained nausea.

ASTAlkaline phosphataseBilirubinGGT
Why people use it

Symptoms it's matched to.

Where this appears in the symptom-to-supplement map, ranked by relevance.

Anxiety

68% relevance

Kavalactones reduce neuronal excitability and may support GABAergic calming.1,2

MoodModerate evidenceRoot-only standardized extract

Avoid in liver disease, alcohol use, and sedative medication use.

Muscle tension from stress

42% relevance

Kavalactones may produce muscle relaxation and anxiolysis.

MusculoskeletalEmerging evidenceLow-dose root extract

Do not drive after sedating doses.

Difficulty falling asleep

38% relevance

May help when sleep difficulty is anxiety-driven.1,2

SleepEmerging evidenceEvening low-dose kava

Not preferred for chronic nightly use because of liver and sedation concerns.

Safety

Full safety detail.

Side effects

  • Drowsiness
  • Dizziness
  • GI upset
  • Headache
  • Mouth numbness
  • Dry scaly skin with heavy use
  • Liver enzyme elevation or rare severe liver injury

Contraindications

  • Liver disease or elevated liver enzymes2,3
  • Heavy alcohol use
  • Pregnancy and breastfeeding
  • Use with benzodiazepines, barbiturates, opioids, sleep medications, antipsychotics, or alcohol without clinician supervision
  • Parkinson disease unless clinician-approved
  • Before surgery
Interactions

Interaction records.

SeriousCaution

Melatonin

Both can impair alertness; kava also carries liver safety concerns.

Recommendation: Avoid routine stacking and do not combine before driving, alcohol use, or sedative medication use.

SeriousCaution

Ashwagandha

Both can cause sedation, and both have rare liver-injury concerns in case reports.

Recommendation: Avoid high-dose or long-duration combination; stop for liver symptoms or unusual fatigue.

ModerateCaution

5-HTP

Both may affect CNS state and sleepiness; 5-HTP adds serotonergic considerations.

Recommendation: Avoid combining with antidepressants or sedatives unless clinician-reviewed.

Sources

Sources, by evidence tier.

Numbered references. Citations throughout the page link here.

Meta-analyses & systematic reviews

1
  • 1Kava extract for treating anxietyNeeds sourceNo linkPittler MH et al. · Cochrane Database of Systematic Reviews · 2003

    Meta-analysis of controlled trials suggested anxiolytic benefit, with safety caveats.

Randomized controlled trials

1
  • 2Kava in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Randomized, Placebo-Controlled StudyNeeds sourceNo linkSarris J et al. · Journal of Clinical Psychopharmacology · 2013

    Kava was evaluated for GAD symptoms with liver function monitoring.

Reviews & position papers

1
  • 3Kava hepatotoxicity--a clinical reviewNeeds sourceNo linkTeschke R et al. · Annals of Hepatology · 2010

    Structured causality assessments identified probable and possible cases of kava-associated liver injury.

Keep exploring

Deep dives & adjacent profiles.

This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.

Use this with your stack

Kava in NutriStack.

Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.